CSCI

COSCIENS Biopharma Inc.

Healthcare · USD

Set alert

Price alert · CSCI

All alert types
2.72 USD 0.00 0.00%
As of Jul 7, 2026
2.72 Day range 2.72
2.50 52-week range 11.10
YTD
+33.99%
1 year
+33.99%
Open
2.72
Prev close
2.72
Mkt cap
8.79M
Vol
0
Avg vol
5.38K
EPS
-4.46
P/E
0.00
Div yield
0.00%
More statistics
Low
2.72
High
2.72
Forward P/E
0.00
Beta
0.00
Short ratio
0.31
Inst. own
6.35%
Dividend
0.00
Ex-div date
50-d avg
3.25
200-d avg
5.61
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CSCI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.5×
FY 2015: 2.5×FY 2016: 3.8×FY 2017: -17.6×FY 2018: -63.0×FY 2019: -16.2×FY 2020: 9.0×FY 2021: 5.7×FY 2022: 3.2×FY 2023: -4.2×FY 2024: -0.5×
FY 2015 5y median 3.2× FY 2024
P/S 0.5×
FY 2015: 1.6×FY 2016: 1.3×FY 2017: 1.3×FY 2018: 1.7×FY 2019: 1.4×FY 2020: 1.2×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 2.1×FY 2024: 0.5×
FY 2015 5y median 1.0× FY 2024
P/B 0.5×
FY 2015: 0.4×FY 2016: 0.8×FY 2017: 0.7×FY 2018: 0.9×FY 2019: 0.8×FY 2020: 0.8×FY 2021: 0.6×FY 2022: 0.6×FY 2023: 0.7×FY 2024: 0.5×
FY 2015 5y median 0.6× FY 2024
P/FCF -0.5×
FY 2015: -75.2×FY 2016: -180×FY 2017: -6.9×FY 2018: -5.9×FY 2019: -1.0×FY 2020: 4.7×FY 2021: 6.3×FY 2022: 3.0×FY 2023: -4.4×FY 2024: -0.5×
FY 2015 5y median 3.0× FY 2024
EV/EBITDA 0.5×
FY 2015: 4.6×FY 2016: 1.9×FY 2017: -334×FY 2018: 1.0×FY 2019: -51.9×FY 2020: 4.0×FY 2021: 2.4×FY 2022: 1.1×FY 2023: -4.5×FY 2024: 0.5×
FY 2015 5y median 1.1× FY 2024
EV/Sales -0.5×
FY 2015: 1.8×FY 2016: 0.8×FY 2017: 0.9×FY 2018: 1.6×FY 2019: 1.5×FY 2020: 1.0×FY 2021: 0.7×FY 2022: 0.5×FY 2023: 1.4×FY 2024: -0.5×
FY 2015 5y median 0.7× FY 2024
FCF Yield -220.0%
FY 2015: -1.3%FY 2016: -0.6%FY 2017: -14.5%FY 2018: -16.8%FY 2019: -103.1%FY 2020: 21.5%FY 2021: 15.8%FY 2022: 32.9%FY 2023: -22.5%FY 2024: -220.0%
FY 2015 5y median 15.8% FY 2024

Profitability

Gross Margin 49.3%
FY 2015: 65.9%FY 2016: 68.4%FY 2017: 56.3%FY 2018: 52.9%FY 2019: 42.3%FY 2020: 50.4%FY 2021: 60.9%FY 2022: 58.7%FY 2023: 41.1%FY 2024: 49.3%
FY 2015 5y median 50.4% FY 2024
Operating Margin -132.6%
FY 2015: 34.0%FY 2016: 43.9%FY 2017: 20.6%FY 2018: 1.1%FY 2019: -4.6%FY 2020: 14.0%FY 2021: -81.3%FY 2022: 29.6%FY 2023: -64.8%FY 2024: -132.6%
FY 2015 5y median -64.8% FY 2024
Net Margin -111.1%
FY 2015: 46.1%FY 2016: 26.5%FY 2017: -7.4%FY 2018: -2.7%FY 2019: -8.8%FY 2020: 12.3%FY 2021: 19.6%FY 2022: 23.7%FY 2023: -48.8%FY 2024: -111.1%
FY 2015 5y median 12.3% FY 2024
ROE -116.3%
FY 2015: 11.8%FY 2016: 16.2%FY 2017: -4.3%FY 2018: -1.4%FY 2019: -5.1%FY 2020: 8.7%FY 2021: 12.1%FY 2022: 14.5%FY 2023: -16.6%FY 2024: -116.3%
FY 2015 5y median 8.7% FY 2024
ROIC -65.0%
FY 2015: 33.2%FY 2016: 16.2%FY 2017: 10.8%FY 2018: 0.1%FY 2019: -2.3%FY 2020: 9.7%FY 2021: -73.9%FY 2022: 17.7%FY 2023: -16.2%FY 2024: -65.0%
FY 2015 5y median -16.2% FY 2024
ROA -43.7%
FY 2015: 31.3%FY 2016: 13.7%FY 2017: -3.4%FY 2018: -1.2%FY 2019: -4.2%FY 2020: 6.4%FY 2021: 10.8%FY 2022: 12.4%FY 2023: -14.7%FY 2024: -43.7%
FY 2015 5y median 6.4% FY 2024

Growth (YoY)

Revenue 93.0%
FY 2015: 0.4%FY 2016: 32.3%FY 2017: 1.0%FY 2018: -17.2%FY 2019: 15.8%FY 2020: 20.3%FY 2021: 13.7%FY 2022: 8.1%FY 2023: -51.0%FY 2024: 93.0%
FY 2015 FY 2024
Operating Income -294.9%
FY 2015: 51.9%FY 2016: 70.6%FY 2017: -52.7%FY 2018: -95.5%FY 2019: -577.6%FY 2020: 469.4%FY 2021: -761.0%FY 2022: 139.4%FY 2023: -207.2%FY 2024: -294.9%
FY 2015 FY 2024
EPS (diluted) -213.8%
FY 2015: 179.3%FY 2016: -37.0%FY 2017: -120.2%FY 2018: 69.8%FY 2019: -269.2%FY 2020: 277.1%FY 2021: 56.5%FY 2022: 39.8%FY 2023: -201.6%FY 2024: -213.8%
FY 2015 FY 2024
Free Cash Flow -376.1%
FY 2015: 92.5%FY 2016: 55.6%FY 2017: -2622.4%FY 2018: -27.5%FY 2019: -489.6%FY 2020: 120.6%FY 2021: -26.9%FY 2022: 124.1%FY 2023: -167.1%FY 2024: -376.1%
FY 2015 FY 2024

Financial Health

Current Ratio 3.3×
FY 2015: 0.3×FY 2016: 4.5×FY 2017: 2.2×FY 2018: 2.9×FY 2019: 3.7×FY 2020: 1.2×FY 2021: 1.0×FY 2022: 1.6×FY 2023: 6.5×FY 2024: 3.3×
FY 2015 5y median 1.6× FY 2024
Quick Ratio 2.9×
FY 2015: 0.2×FY 2016: 4.0×FY 2017: 1.9×FY 2018: 2.8×FY 2019: 3.3×FY 2020: 1.0×FY 2021: 0.8×FY 2022: 1.3×FY 2023: 4.2×FY 2024: 2.9×
FY 2015 5y median 1.3× FY 2024
Debt / Equity 0.2×
FY 2015: 0.1×FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×
FY 2015 5y median 0.1× FY 2024
Net Debt / EBITDA 1.0×
FY 2015: 0.6×FY 2016: -1.1×FY 2017: 127×FY 2018: -0.1×FY 2019: -3.7×FY 2020: -0.6×FY 2021: -1.0×FY 2022: -1.3×FY 2023: 1.9×FY 2024: 1.0×
FY 2015 5y median -0.6× FY 2024
Interest Coverage -142×
FY 2015: 0.0×FY 2016: 160×FY 2017: 41.4×FY 2018: 2.7×FY 2019: -0.6×FY 2020: 1.7×FY 2021: -413×FY 2022: 30.2×FY 2023: -34.0×FY 2024: -142×
FY 2015 5y median -34.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31